NewsBite

Lunch Wrap: ‘Trump slump’ hits ASX again as pharma, China tariffs send stocks tumbling

ASX cops a 1.4pc beating as the US-China trade spat rocks markets, pharma faces tariff pain, oil dives, and Aussie miners take a hit.

The ASX dropped over 1% pretty quickly on Wednesday, practically wiping out over $30 billion in market value as the US-China trade war tensions escalated. It's now down 1.48% at the time of publishing this article.

In the US overnight, the S&P 500 dropped 1.57%, while the tech-heavy Nasdaq fell by 2.15%.

This comes after the White House dropped the hammer with a 104% tariff on Chinese goods, all because China fired back with a 34% tariff on US imports earlier.

China isn’t backing down... at this stage.

Premier Li Qiang’s been pretty vocal, saying China has all the right tools to absorb these shocks, and said the Chinese economy will keep growing in 2025.

But it’s hard to shake the feeling that something’s about to break when two economic powerhouses are butting heads this hard.

The bad news, though, doesn’t end there.

Trump’s on the verge of pushing another round of tariffs, this time targeting pharmaceuticals.

Experts reckon Aussie pharmaceutical exporters could take a hit of around $1.6 billion a year, with CSL (ASX:CSL) already feeling the sting as its stock price plummeted 4% this morning.

And let’s not forget about oil. The price of crude took another massive dive last night, with crude prices sliding to four-year lows.

The Aussie dollar, meantime, is now trading at just under US60c, its lowest level in years as iron ore prices tumbled to a seven-month low.

Back home, the impact of this trade war is hitting the ASX’s big miners especially hard this morning.

Investors were pulling out of big names like BHP (ASX:BHP), Rio Tinto (ASX:RIO), CSL (ASX:CSL) and Woodside Energy Group (ASX:WDS).

Source: Market Index
Source: Market Index
Source: Market Index
Source: Market Index

In large caps news, fund manager Regal Partners (ASX:RPL) fell 7% after its funds under management (FUM) dropped to $16.5 billion from $18 billion in the March quarter.

Fellow fundie GQG Partners (ASX:GQG), however, saw a nice uptick of 4%, with net flows climbing by 64% in March, showing that some fundies are still holding their ground despite the chaos.

ASX SMALL CAP WINNERS

Here are the best performing ASX small cap stocks for April 9 :

Security Description Last % Volume MktCap
OSX Osteopore Limited 0.045 181% 36,618,975 $1,933,897
ENT Enterprise Metals 0.003 50% 333,333 $2,356,635
VML Vital Metals Limited 0.003 50% 1,265,416 $11,790,134
AJL AJ Lucas Group 0.007 40% 2,641,039 $6,878,648
PVT Pivotal Metals Ltd 0.009 38% 5,704,797 $5,896,968
AOA Ausmon Resorces 0.002 33% 450,000 $1,966,820
GGE Grand Gulf Energy 0.002 33% 508,000 $3,675,581
JAY Jayride Group 0.002 33% 3,000,000 $2,117,588
NNL Nordicresourcesltd 0.115 24% 131,173 $13,706,698
BMM Bayan Mining 0.043 23% 13,700,273 $3,366,631
CND Condor Energy Ltd 0.028 22% 25,878,575 $16,139,521
OD6 Od6Metalsltd 0.035 21% 135,500 $4,618,126
ATG Articore Group Ltd 0.175 21% 1,144,513 $41,307,145
GAS State GAS Limited 0.030 20% 200,647 $9,815,022
LM1 Leeuwin Metals Ltd 0.180 20% 1,770,234 $12,644,957
FBR FBR Ltd 0.006 20% 2,961,166 $28,178,159
ROG Red Sky Energy. 0.006 20% 1,958,647 $27,111,136
CTQ Careteq Limited 0.014 17% 14,501 $2,845,425
EE1 Earths Energy Ltd 0.007 17% 902,602 $3,179,785
FCT Firstwave Cloud Tech 0.014 17% 49,999 $20,562,224
IXR Ionic Rare Earths 0.007 17% 12,615,696 $31,430,570
SHN Sunshine Metals Ltd 0.007 17% 22,029,731 $11,905,869
SPX Spenda Limited 0.007 17% 81,269 $27,691,293
EMD Emyria Limited 0.029 16% 97,162 $12,281,104
GED Golden Deeps 0.022 16% 11,782,681 $3,365,388

Osteopore's (ASX:OSX) shares skyrocketed after the company secured European Union Medical Device Regulation (EU MDR) approval for its custom orthopaedic and cranial implants, marking a huge milestone in its expansion into Europe. This approval allows Osteopore to offer its custom-made implants alongside its already approved off-the-shelf neurosurgical and craniofacial products.

With the European orthopaedic market set to grow at 3.3% annually and the cranial implant market at 9.4%, Osteopore said it was well-positioned to take advantage of this demand. The company’s exclusive distribution deal with Zimmer Biomet further strengthens its presence, creating an opportunity for Osteopore to broaden its reach across Europe.

Bayan Mining and Minerals (ASX:BMM) has just secured an exclusive deal with Macquarie University for a solar panel recycling tech that uses microwave heating to separate valuable materials like silver and silicon. The new method makes recycling way easier by avoiding the high heat and harsh chemicals used in traditional methods, which is a big win for both the environment and the economy. With the global market for solar cell recycling booming, Bayan believes this tech positions it at the forefront of a major growth opportunity in critical mineral recovery.

Condor Energy (ASX:CND) has got the green light on a 3 billion barrel oil potential across five prospects in the Tumbes Basin off Peru. The Bonito prospect alone holds a billion barrels, with the majority of the resources in a proven oil zone. This independent estimate from leading consultants shows big exploration potential, and builds on Condor’s already discovered gas field. The company’s now in talks with multiple parties as it moves forward with the farm-out process.

Red Sky Energy (ASX:ROG) reported some solid numbers coming out of its Block 6/24 offshore Angola, with a net 5.1 million barrels of contingent resources from the Cegonha oil field. There's also an additional 11 million barrels of potential across three other prospects in the area. Red Sky said it’s got its sights set on rapid production and cash flow. The company’s also eyeing a promising pre-salt structure under the Ibis prospect, with plenty of room for more exploration and growth.

ASX SMALL CAP LOSERS

Here are the worst performing ASX small cap stocks for April 9 :

Code Name Price % Change Volume Market Cap
MOM Moab Minerals Ltd 0.001 -50% 719,849 $3,467,332
CDT Castle Minerals 0.002 -33% 771,452 $5,783,469
RAS Ragusa Minerals Ltd 0.016 -30% 592,667 $3,279,772
MEG Megado Minerals Ltd 0.011 -27% 1,609,543 $6,295,249
AOK Australian Oil. 0.002 -25% 1,000,000 $2,003,566
ABE Ausbondexchange 0.031 -23% 26,333 $4,506,725
PKD Parkd Ltd 0.028 -20% 9,445 $3,640,486
AMS Atomos 0.004 -20% 1,800 $6,075,092
AVE Avecho Biotech Ltd 0.004 -20% 112,489 $15,846,485
AYT Austin Metals Ltd 0.004 -20% 280,000 $7,870,957
CTN Catalina Resources 0.002 -20% 39,285 $3,790,655
IPB IPB Petroleum Ltd 0.004 -20% 75,000 $3,532,015
OVT Ovanti Limited 0.004 -20% 3,000,000 $13,507,739
APC APC Minerals 0.009 -18% 3,065,222 $1,288,904
ENL Enlitic Inc. 0.046 -18% 516,105 $32,234,120
PBL Parabellumresources 0.035 -17% 670,638 $2,616,600
BTC BTC Health Ltd 0.050 -17% 9,092 $19,519,398
ADO Anteotech Ltd 0.010 -17% 1,301,812 $32,463,604
AZL Arizona Lithium Ltd 0.005 -17% 1,870,857 $27,370,887
BP8 Bph Global Ltd 0.003 -17% 203,588 $1,824,924
EMU EMU NL 0.020 -17% 137,300 $4,646,434
W2V Way2Vatltd 0.005 -17% 75,000 $5,604,001
SPN Sparc Tech Ltd 0.135 -16% 142,129 $15,339,672
PCL Pancontinental Energ 0.006 -14% 8,456,193 $56,956,101

IN CASE YOU MISSED IT

Leveraging petrophysics, Riversgold (ASX:RGL) has confirmed the high chargeability and low resistivity of a sulphide copper-silver sample from the Saint John project in Canada, which also graded at 10.15% copper and 65.8 g/t silver. The results give RGL a strong geophysical signature to find more mineralisation via airborne surveys.

Caprice Resources (ASX:CRS) has gained a wealth of commodity and exploration expertise in the form of incoming non-executive director Robert Waugh, who played a pivotal role in bringing Musgrave Minerals from IPO, through several gold discoveries, until it was acquired by Ramelius Resources for more than $200 million.

In one of the last steps before producing battery-grade lithium carbonate, Anson Resources (ASX:ASN) has begun “polishing” 43,500 gallons of highly purified lithium chloride eluate produced at the Green River lithium project in the US.

At Stockhead, we tell it like it is. While Riversgold, Caprice Resources, and Anson Resources are Stockhead advertisers, they did not sponsor this article.

This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions. 

Originally published as Lunch Wrap: ‘Trump slump’ hits ASX again as pharma, China tariffs send stocks tumbling

Original URL: https://www.couriermail.com.au/business/stockhead/lunch-wrap-trump-slump-hits-asx-again-as-pharma-china-tariffs-send-stocks-tumbling/news-story/213d43fff5f93791125102c0ec3bee7f